Litcius/Paper detail

Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B

Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park

2021Hepatology International24 citationsDOIOpen Access PDF

Topics & Concepts

EntecavirMedicineHepatocellular carcinomaHepatologyTenofovir alafenamideInternal medicineChronic hepatitisTenofovirGastroenterologyColorectal surgeryAbdominal surgerySurgical oncologyOncologyVirologyLamivudineVirusHuman immunodeficiency virus (HIV)Viral loadAntiretroviral therapyHepatitis B Virus StudiesHepatitis C virus researchHepatocellular Carcinoma Treatment and Prognosis
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B | Litcius